CLICK HERE FOR THOUSANDS OF FREE BLOGGER TEMPLATES »

06 June 2012

EULAR2012 Abstracts

Abstracts 2012

Accepted Abstracts are published with the intention to offer delegates an opportunity to prepare for planning to participate in a particular session or to visit the Poster Sessions during EULAR 2012.


Full content is available now and is not subject to embargo any longer.

Use this link to access the FULL ABSTRACT TEXT Publication Website >>

Or use the link below. it's same as the above text link but I prefer seeing the actual link if I am being taken away from the original site.


https://b-com.mci-gr.../EULAR2012.aspx


I was going to post the titles and links to the abstracts but there are over 3400 of them, so I will not be doing that! But I'll post a few that jump out at me. I am not even taking time to go through all 69 pages of abstracts. I am also not reading these since I do not wanna have my eyes glaze over today. I have a bit of a headache and I know plowing through the scientific abstracts will make it worse.


CD8+ T CELLS IN RHEUMATOID ARTHRITIS - DIFFERENCES BETWEEN REMISSION AND ACTIVE DISEASE

CYTOKINE PROFILE IN CD4+ FOXP3+ LYMPHOCYTES OF RA PATIENTS TREATED WITH TOCILIZUMAB AND CLINICAL CORRELATION (DAS28-CPR, RHEUMATOID FACTOR

ANALYSIS OF RECOMBINANT MONOCLONAL ANTIBODIES FROM SINGLE B CELLS REVEALS EARLY DEFECTS OF B CELL TOLERANCE CHECKPOINTS IN PATIENTS WITH SJÖGREN'S SYNDROME

ASSOCIATIONS OF PLASMABLASTS WITH DISEASE ACTIVITY AND THERAPIES FOR RHEUMATOID ARTHRITIS

IL17 AND IFN GAMMA ARE IMPORTANT IN THE SEVERITY OF KIDNEY DISEASE IN SLE

B CELL DISTURBANCES DIFFER BETWEEN TAKAYASU ARTERITIS AND GIANT CELL VASCULITIS

CD4+CD25-GITR+ REGULATORY T CELLS ARE EXPANDED IN THE BLOOD, DISPLAY SUPPRESSIVE FUNCTION AND ARE INVERSELY CORRELATED WITH DISEASE ACTIVITY IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME

ANALYSIS OF GENETIC POLYMORPHISMS IN FOLATE PATHWAY AFFECTING THE EFFICACY OF METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS

ASSOCIATIONS BETWEEN ENOS POLYMORPHISMS AND SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUS: A META-A

IMPACT OF ADDITIONAL GENETIC MARKERS OF RHEUMATOID ARTHRITIS ON PATTERN OF FUNCTIONAL STRESS RESPONSES

GENE-GENE INTERACTION AND EARLY RHEUMATOID ARTHRITIS: EFFECTS ON THE RESPONSE TO THERAPY

A PLS MULTIVARIATE MODEL TO PREDICT RA RADIOLOGICAL SEVERITY BY SELECTING KEY PREDICTORS FROM A LARGE PANEL OF SNPS AND ENVIRONMENTAL FACTORS

TUBULOINTERSTITIAL INJURY IN LUPUS NEPHRITIS AND GENE EXPRESION OF KIM-1.

ASSOCIATION STUDY OF GENETIC RISK VARIANTS FOR PSORIASIS IN A LARGE COHORT OF PSORIATIC ARTHRITIS, PSORIASIS AND CONTROLS OF THE SPANISH POPULATION AND ASSOCIATION WITH RELEVANT CLINICAL SUBPHENOTYPES.

HLA-G MAY PREDICT THE DISEASE COURSE IN PATIENTS WITH EARLY ARTHRITIS

THE UNCOUPLING TJ CLUSTER IS A PROTECTIVE FACTOR AGAINST OSTEOARTHRITIS IN SPAIN AND UK

MICRORNA-223 IN SYNOVIAL TISSUE OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS.

CNSTREAM2: A POWERFUL TOOL FOR THE STUDY OF THE GENETIC BASIS OF RHEUMATIC DISEASES.

ASSOCIATION OF FCGR2A WITH RESPONSE TO INFLIXIMAB IN RHEUMATOID ARTHRITIS PATIENTS

GENETIC POLYMORPHISM IN GDF-5 GENE AS RISK FACTOR FOR DEVELOPMENT AND PROGRESSION OF OSTEOARTHRITIS

REGULATORY T CELLS IN RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS AND BEHCET'S DISEASE

NO EVIDENCE FOR PREMATURE IMMUNOSENESCENCE IN NEWLY DIAGNOSED, NON TREATED, SHARED EPITOPE-POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS

ADALIMUMAB ELICITS A RESTRICTED ANTI-IDIOTYPIC ANTIBODY RESPONSE IN AUTOIMMUNE PATIENTS RESULTING IN FUNCTIONAL NEUTRALIZATION.

THE ABNORMALITY AND CLINICAL SIGNIFICANCE OF T HELPER 9 CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS

GAMMADELTA T CELLS AND THEIR INTRACELLULAR CYTOKINE PROFILE IN PERIPHERAL BLOOD OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

ENHANCED PHAGOCYTOSIS AND SUPEROXIDE ANION PRODUCTION BY NEUTROPHILS IN EARLY RHEUMATOID ARTHRITIS PATIENTS RELATED TO POSITIVITY TO ANTI-CYCLIC CITRULLINATED PEPTIDES AND RHEUMATOID FACTOR

EXPRESSION OF NLRP3-INFLAMMASOME-RELATED TRANSCRIPTS IN PERIPHERAL BLOOD OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB


DISTRIBUTION OF BLOOD DENDRITIC CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS TREATED WITH ETANERCEPT.ANALYSIS OF CIRCULATING IMMUNE COMPLEXES CONTAINING PAIN-ASSOCIATED MOLECULES IN KNEE OSTEOARTHRITIS

MATERNAL COLLAGEN-INDUCED ARTHRITIS AND CO-ADMINISTRATION OF ETANERCEPT CHANGE TNF PROTEIN LEVEL IN PLACENTA AND EPIPHYSEAL CARTILAGE IN FETUSES

THE EFFECT OF PHYSICAL EXERCISE IN THE CYTOKINES LEVELS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

THE ENDOGENOUS ANGIOSTATIC MEDIATORS ENDOSTATIN AND THROMBOSPONDIN-1 ARE INCREASED IN PSORIATIC ARTHRITIS

SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) FOR MONITORING INFLAMMATORY ACTIVITY IN DIFFERENT RHEUMATIC DISEASES

HIGHER LEVELS OF METASTASIS-INDUCING S100A4 PROTEIN LEVELS ARE ASSOCIATED WITH LESS FAVOURABLE TREATMENT RESPONSE TO DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN FEMALE PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS

SERUM INTERLEUKIN-34 LEVELS INCREASE IN RHEUMATOID ARTHRITIS BUT ARE NOT ASSOCIATED WITH JOINT DAMAGE

EFFECT OF CHONDROITIN SULFATE ON THE FACTORS INVOLVED IN SYNOVIAL INFLAMMATION

HIGHER LEVELS OF TH17/23, TH2 AND PROINFLAMMATORY CYTOKINES LEVELS IN SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS COMPARED WITH PSORIATIC ARTHRITIS

THE ASSOCIATION OF INTERLEUKIN 23 CONCENTRATION WITH CLINICAL COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS

ANGIOGENIC AND ANGIOSTATIC MEDIATORS IN SPONDYLOARTHRITIS

IL-6 BLOCKADE ENHANCES THE THERAPEUTIC EFFECT OF STEROIDS

A UNIQUE SUBSET OF RHEUMATOID ARTHRITIS DEFINED BY A DISTINCT SERUM CYTOKINE PROFILE [I've LONG thought that there are subsets of RA but I've not seen much on docs discussing the subsets. Just as there are subsets to juvenile arthritis, I fully think there are similar ones with RA. Which would explain why some people are not bothered very much by the symptoms many of us have.]


IL-18: A SEROLOGICAL BIOMARKER TO DISCRIMINATE AOSD FROM SEPSIS [AOSD is more commonly known as Still's Disease.]

SERUM ADIPOKINE (ADIPONECTIN, LEPTIN, VISFATIN, AND RESISTIN) LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS ARE DIFFERENTIALLY MODULATED BY DISEASE ACTIVITY BUT MAY NOT CONTRIBUTE TO TREATMENT RESISTANCE

THE SOLUBLE FORM OF CD18 IS ASSOCIATED WITH CLINICAL FINDINGS, CRP AND MRI ACTIVITY IN SPONDYLOARTHRITIS

SECRETED FRIZZLED-RELATED PROTEIN 5 INHIBITS EXPRESSION OF PRO-INFLAMMATORY MEDIATORS BY DOWN-REGULATION OF JNK IN RHEUMATOID ARTHRITIS

A NOVEL PHARMACOPROTEOMIC STUDY CONFIRMS THE SYNERGISTIC CHONDROPROTECTIVE EFFECT OF CHONDROTIN SULFATE AND GLUCOSAMINE HYDROCHLORIDE.

A SIMPLIFIED METHOD TO DETERMINE JOINT LOADING AS A SURROGATE MARKER OF PAIN/DISABILITY IN A CANINE MODEL OF OSTEOARTHRITIS, VALIDATED USING FORCE PLATE ANALYSES AS A GOLD STANDARD.

INTRA-ARTICULAR GLUCOCORTICOID INJECTIONS DECREASE THE NUMBER OF STEROID HORMONE RECEPTOR POSITIVE CELLS IN SYNOVIAL TISSUE OF PATIENTS WITH PERSISTENT KNEE ARTHRITIS

REBAMIPIDE ATTENUATES PAIN SEVERITY AND CARTILAGE DEGENERATION IN A RAT MODEL OF OSTEOARTHRITIS BY DOWNREGULATING OXIDATIVE DAMAGE AND CATABOLIC ACTIVITY IN CHONDROCYTES

IMPAIRED HEALING OF ANTERIOR CRUCIATE LIGAMENT CORRELATES WITH KININS EXPRESSION

REGULATION OF SOCS1, SOCS2 AND SOCS3 EXPRESSION IN PATIENTS WITH EARLY ARTHRITIS.

THERAPY RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS AND CONCOMITANT FIBROMYALGIA

FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH SPONDYLOARTHRITIS

DELAY ON FIBROMYALGIA DIAGNOSIS AND ITS IMPACT ON LONG TERM OUTCOMES

FIBROMYALGIA IN EGYPTAN PATIENTS ON HAEMODIALYSIS. DOES HEPATITIS C VIRAL INFECTION HAS A ROLE? [yeah I know the word has should be have in order to have sub/verb agreement]

STUDY ON FACTORS ASSOCIATED WITH CHRONIC FATIGUE SYNDROME (FIBROMYALGIA) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS [on this idk why they say assoc w/CFS then have fibro in parentheses. CFS and fibro aren't the same and interchangeable so not sure what that's about]

OVERACTIVE LIFESTYLE IN PATIENTS WITH FIBROMYALGIA AS A CORE FEATURE OF BIPOLAR SPECTRUM DISORDER

SURGICAL INTERVENTIONS OF THE CERVICAL AND/OR LUMBAR SPINE IN PATIENTS WITH FIBROMYALGIA

OBESITY AND INSULIN RESISTANCE IN FIBROMYALGIA PATIENTS

OBESITY AND FIBROMYALGIA: RELATIONSHIP BETWEEN BODY MASS INDEX AND SEVERITY OF THE SYMPTOMS

CLUSTER ANALYSIS OF CLINICAL DATA IDENTIFIES FIBROMYALGIA SUBGROUPS

MEDIATION OF CHILDHOOD/ADOLESCENCE MALTREATMENT AND ADULT FIBROMYALGIA SYNDROME BY DEPRESSION – A CASE CONTROL STUDY

THE INFLUENCE OF WEATHER ON DAILY PAIN AND FATIGUE IN FEMALE PATIENTS WITH FIBROMYALGIA [seems interesting. I fully believe weather influences both FMS and RA symptoms, but some docs still deny it]

EFFECTS OF A ONE WEEK MULTIDISCIPLINARY INPATIENT SELF-MANAGEMENT PROGRAMME FOR PATIENTS WITH FIBROMYALGIA: A RANDOMISED CONTROLLED TRIAL [I am a BIG believer in self-management programs.]

CONCOMITANT FIBROMYALGIA AND DEPRESSION MIGHT BE A CAUSE OF DISCREPANCY BETWEEN BOOLEAN REMISSION AND DAS28 REMISSION IN RHEUMATOID ARTHRITIS

ASSESSMENT OF ART THERAPY PROGRAM FOR WOMEN WITH FIBROMYALGIA: RANDOMIZED, CONTROLLED, BLINDED STUDY

DAS-28, SDAI AND CDAI IN THE PATIENTS WITH RHEUMATOID ARTHRITIS AND CONCOMITANT FIBROMYALGIA

SIMILARITIES BETWEEN FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME: A SINGLE DISEASE? [after my earlier comment I found this one!]

ADHERENCE AND EFFECTIVENESS OF A SIMPLE PROGRAM OF HOME-MADE STRETCHING IN FIBROMYALGIA

SMOKING IS ASSOCIATED WITH REDUCED IGF-1 LEVELS AND HIGHER PAIN EXPERIENCE IN PATIENTS WITH FIBROMYALGIA

MONOTHERAPY VERSUS COMBINATION THERAPY IN THE TREATMENT OF FIBROMYALGIA

BENEFITS OF A MULTIDISCIPLINARY TREATMENT IN WOMEN WITH FIBROMYALGIA AND OBESITY

THE EFFECTIVENESS OF SHIATSU ON PAIN, SLEEP QUALITY AND BALANCE CONFIDENCE OF FIBROMYALGIA PATIENTS: A CONTROLLED CLINICAL TRIAL

FATIGUE IN RHEUMATOID ARTHRITIS PATIENTS: THE IMPACT OF DISEASE ACTIVITY, PAIN, DISABILITY AND DEPRESSIVE DISORDERS

NEUROPATHIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS

NEGATIVE LIFE EVENTS BEFORE THE DISEASE ONSET AND DISEASE OUTCOME IN LONG TERM FOLLOW UP OF PAIN, SLEEP, FATIGUE AND GENERAL WELL-BEING

ATTENTIONAL IMPAIRMENT IN CHRONIC CENTRAL AND PERIPHERAL PAIN: CONTROLLED STUDY


DETECTION OF SYNOVITIS, BONE EROSIONS, AND BONE MARROW OEDEMA IN PATIENTS WITH INFLAMMATORY HAND PAIN - A COMPARISON OF LOW FIELD MRI AND HIGH FIELD MRI.

PREDICTIVE VALUE OF ULTRASOUND ON THE RESPONSE TO STEROID INFILTRATIONS IN THE PAINFUL SHOULDER: A PROSPECTIVE CONTROLLED SINGLE-BLIND STUDY OF 70 PATIENTS

COMPARISON OF AGREEMENT AND RESPONSIVENESS TO TREATMENT EFFECTS OF 100MM VISUAL ANALOG SCALE AND 11 POINT NUMERICAL RATING SCALE TO ASSESS WRIST PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS.

PREDICTORS OF OUTCOME OF MULTIDISCIPLINARY TREATMENT IN CHRONIC WIDESPREAD PAIN: AN OBSERVATIONAL STUDY

POORER POSTURAL CONTROL OF PATIENTS WITH LOW BACK PAIN COMPARED TO A CONTROL GROUP

THE EFFECT OF CUSTOMIZED INSERTS ON PAIN, PHYSICAL FUNCTION AND QUALITY OF LIFE IN RHEUMATOLOGICAL PATIENTS WITH FOOT PAIN

THE RELATIONSHIP BETWEEN PAIN, PHYSICAL ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH KNEE OSTEOARTHRITIS

THE EFFECTS OF LOW BACK PAIN ON QUALITY OF LIFE AND FUNCTIONAL DISABILITY IN NURSES WITH LOW BACK PAIN

A GRIP FORCE OVER 104 NEWTON IS ASSOCIATED TO LESS ACTIVITY LIMITATIONS AND PAIN IN WOMEN WITH HAND OSTHEOARTHRATIS

PAIN MANAGEMENT: OBSERVATION AND SIDE EFFECTS - FRENCH SITUATION

A LARGE RANDOMISED, CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF TOPICAL KETOPROFEN IN TRANSFERSOME GEL WITH ORAL CELECOXIB FOR OSTEOARTHRITIS KNEE PAIN

THE ASSOCIATION BETWEEN PAIN AND ULTRASONOGRAPHIC FEATURES OF HAND OSTEOARTHRITIS IN FINGER JOINTS

PAIN, HEALTH-RELATED QUALITY OF LIFE AND HEALTH STATUS IN GOUT IN EUROPE

BODY MASS INDEX AND DEPRESSION ARE INDEPENDENTLY ASSOCIATED WITH KNEE PAIN AND ACTIVITY LIMITATIONS IN KNEE OSTEOARTHRITIS: RESULTS FROM THE AMS-OA COHORT

PAIN SCORES ARE THE PRIMARY EXPLANATORY VARIABLE FOR HIGHER GLOBAL ESTIMATES BY PATIENTS COMPARED TO DOCTORS IN PATIENTS WITH ALL RHEUMATIC DISEASES


ASSESSMENT OF POSTURAL CONTROL, STRENGHT OF LOWER LIMBS A COMPARISON OF INFLAMMATORY BACK PAIN CRITERIA AS DIAGNOSTIC TOOL IN ANKYLOSING SPONDYLITIS AND EARLY AXIAL SPONDYLOARTHRITIS

ND PAIN IN INDIVIDUALS WITH AND WITHOUT FIBROMYALGIA


EFFICACY AND SAFETY OF DICLOFENAC DIETHYLAMINE 1.16% GEL IN THE TREATMENT OF ACUTE NECK PAIN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

NO PROSPECTIVE ASSOCIATION FOUND BETWEEN OBESITY AND CHRONIC, WIDESPREAD MUSCULOSKELETAL PAIN IN A POPULATION BASED 20-YEAR PROSPECTIVE FOLLOW-UP STUDY

IDENTIFICATION OF AXIAL SPONDYLOARTHRITIS AMONG PATIENTS WITH CHRONIC BACK PAIN IN PRIMARY CARE – DOES DETERMINATION OF HLA B27 IMPROVE THE PERFORMANCE OF CLINICAL ASSESSMENTS OF INFLAMMATORY BACK PAIN ?

IMPACT OF UVEITIS ON THE PHENOTYPE OF PATIENTS WITH RECENT INFLAMMATORY BACK PAIN. DATA FROM THE DESIR COHORT.

RATIO OF NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN PATIENTS REFERRED BECAUSE OF BACK PAIN IS DEPENDENT ON SYMPTOM DURATION

ASSOCIATION BETWEEN JOINT PAIN SEVERITY AND SERUM LEPTIN LEVELS IN HAND OSTEOARTHRITIS

MARKED BILATERAL SYMMETRICITY OF CARTILAGE DAMAGE, BONE MARROW LESIONS AND MENISCAL DAMAGE IN SUBJECTS WITH KNEE PAIN AND WITH OR WITHOUT RADIOGRAPHIC OSTEOARTHRITIS: THE JOG STUDY


FENOFIBRATE EFFECTS ON PAIN, FUNCTION, CYTOKINE PRODUCTION, AND CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH EROSIVE OSTEOARTHRITIS

BACK PAIN AND QUALITY OF LIFE: 18- AND 24-MONTH FINAL RESULTS FROM THE ITALIAN STUDY ON SEVERE OSTEOPOROSIS (ISSO)


QUALITY OF LIFE AND PAIN EVALUATION IN PATIENTS WITH AND WITHOUT SELF-REPORTED OSTEOPOROSIS - CORPO STUDY: COMPREHENDING OSTEOPOROSIS REAL PERCEPTION AND OVERVIEW

CHRONIC LOW BACK PAIN IN OSTEOPOROTIC FEMALES WITH RHEUMATOID ARTHRITIS A RANDOMIZED CLINICAL TRIAL


PREVALENCE AND SEVERITY OF INSOMNIA IN CHRONIC LOW BACK PAIN PATIENTS

SEXUAL LIFE IS MORE PERTURBED IN MEN THAN WOMEN SUFFERING FROM CHRONIC LOW BACK PAIN. RSULTS OF A CROSS SECTIONAL STUDY IN A MOROCCAN SAMPLE.

ARE FEMALES WITH RHEUMATOID ARTHRITIS CAUGHT IN A VICIOUS CIRCLE OF PAIN, FATIGUE AND SLEEP DISTURBANCE? [I'd be willing to be the answer is YES! And I was right.]

Sleep disturbance is to a higher degree reported by females and is independently associated with increased pain, fatigue and worse mental and physical function. Improving sleep quality may reduce RA impact of disease and should be addressed in daily clinical practice when treating patients with RA.
PAIN MANAGEMENT IN RHEUMATOLOGY– LESSONS FROM A PAIN IN MOTION: FROM THE JOINT TO THE BRAIN, FROM ANALGESICS TO BIOLOGICS.


OFTEN USED BUT RARELY INVESTIGATED: PSYCHOMETRIC PROPERTIES OF COMMON PAIN MEASURES IN RHEUMATOID ARTHRITIS – PRELIMINARY RESULTS FROM AN OUTPATIENT COHORT

ASSESSING NEUROPATHIC PAIN COMPONENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS

THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE.

IMPROVED PHYSICAL FUNCTION, PAIN, AND HEALTH RELATED QUALITY OF LIFE WITH CERTOLIZUMAB PEGOL IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE JRAPID STUDY

HEALTH-RELATED QUALITY OF LIFE (HRQOL) BENEFITS ASSOCIATED WITH REDUCTIONS IN DISEASE ACTIVITY AND PAIN SEVERITY AMONG RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH SECUKINUMAB [I've not heard of secukinumab but I checked Wiki and it says

Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis. It targets member A from the cytokine family of interleukin 17.

NANO-FORMULATED LOWER DOSE NSAIDS PREFERRED BY PATIENTS EXPERIENCING ACUTE PAIN

PAIN CATASTROPHIZING AND PAIN ANXIETY ARE ASSOCIATED WITH PAIN SEVERITY AND WITH BOTH NEUROPATHIC AND FIBROMYALGA PAIN PHENOTYPES IN PSS PATIENTS

RELATIONSHIP BETWEEN CHRONIC LOW BACK PAIN AND MRI OF SACROILIAC JOINTS

INFLUENCE OF ENTHESITIS PAIN ON ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS)

LONG TERM TOLERABILITY AND EFFECTIVENESS OF A SINGLE INJECTION OF 6ML HYLAN G-F 20 IN 451 PATIENTS WITH KNEE OSTEOARTHRITIS PAIN

MOVES: MAGNITUDE OF OSTEOARTHRITIS DISADVANTAGE ON PEOPLE'S LIVES: PAIN IN SELF-REPORTED OSTEOARTHRITIS

BISPHOSPHONATE INTRAVENOUS ALLOWS A RAPID CONTRAST OF PAIN IN COMPLEX REGIONAL PAIN SYNDROME (CRPS)

EFFICACY AND SAFETY OF STEROID INJECTIONS FOR SHOULDER PAIN

EFFECTIVENESS OF FACET JOINT INJECTION IN LOW BACK PAIN [This intrigues me because I've had the facet joint injections before we burnt the nerves off. I know the blocks I had were supposed to be short-acting, but for me I had a longer length of relief than we ever thought would happen.]


MULTIDISCIPLINARY REHABILITATION IN CHRONIC LUMBAR PAIN : LONG-TERM EFFECT ON WORK STATUS.


PRESSURE PAIN THRESHOLD AND PAIN COPING STRATEGIES IN JUVENILE IDIOPATHIC ARTHRITIS: A CROSS-SECTIONAL STUDY

MUSCULO-SKELETAL PAIN AND JOINT HYPERMOBILITY IN CHILDREN: A COMPLEX RELATIONSHIP

EFFICACY AND SECURITY OF ANAKINRA TREATMENT IN PATIENTS WITH SYSTEMIC-ONSET JUVENIL IDIOPATHIC ARTHRITIS: "INITIAL RESULTS FROM A REGISTER OF TWO PEDIATRIC REUMATOLOGIC UNITS FROM SPAIN"

PERFORMANCE OF A PATIENT-BASED ONLINE-QUESTIONNAIRE TO IDENTIFY PATIENTS WITH AXIAL SPONDYLOARTHRITIS (SPA) IN PATIENTS WITH CHRONIC LOW BACK PAIN

LUMBAR FACET JOINT EFFUSION ON 3-D MR MYELOGRAPHY: A SIGN OF RHEUMATOID BACK PAIN?

MULTIMODAL TREATMENT IN A DAY CLINIC EFFECTS THE PAIN EXPERIENCE IN PATIENTS WITH RHEUMATIC DISEASES.

TALKING ABOUT SEXUALITY IN CHRONIC LOW BACK PAIN PATIENTS: BARRIERS AND PATIENT'S EXPECTATIONS

USING THE SF-MCGILL PAIN QUESTIONNAIRE, HOW DO PATIENTS WITH SLE DESCRIBE THEIR PAIN?

REFFECTS OF A YOGA PROGRAM ON PAIN RELIEF, REDUCING ANXIETY AND EXTENDED RANGE OF MOTION OF KNEE IN RHEUMATOID ARTHRITIS PATIENTS

INVESTIGATING THE EFFECT OF ETANERCEPT ON THE PERIPHERAL B CELL COMPARTMENT IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS

JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) MONOCYTES AND MACROPHAGES EXPRESS RAISED LEVELS OF RECEPTORS ASSOCIATED WITH APOPTOTIC CELL CLEARANCE

TOCILIZUMAB INCREASES HEMOGLOBIN PRODUCTION IN PATIENT WITH JUVENILE IDIOPATIC ARTHRITIS AND BETA THALASSEMIC TRAIT

LEPTIN CONCENTRATIONS AND RADIOLOGICAL PROGRESSION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS

DISABILITY IN ADULT PATIENTS WITH IDIOPATHIC JUVENILE ARTHRITIS


PRESSURE PAIN THRESHOLD AND PAIN COPING STRATEGIES IN JUVENILE IDIOPATHIC ARTHRITIS: A CROSS-SECTIONAL STUDY

JUVENILE IDIOPATHIC ARTHRITIS: CAN MOTHER MOOD BE A DETERMINANT FACTOR IN THE CHILD ILLNESS MANAGEMENT?

LEFLUNOMIDE IN THE TREATMENT OF CHRONIC UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS


EXPLORING THE RELATIONSHIPS BETWEEN ADULT JUVENILE IDIOPATHIC ARTHRITIS AND EMPLOYMENT


CORONARY ARTERY ABNORMALITIES IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS


JUVENILE IDIOPATHIC ARTHRITIS ENTHESITIS-RELATED ARTHRITIS (ERA) SUBTYPE: DO BOYS AND GIRLS HAVE A DIFFERENT CLINICAL FENOTYPE AND COURSE?

EQUIVALENCE OF DISEASE ACTIVITY TOOLS FOR JUVENILE IDIOPATHIC ARTHRITIS

8VITAMIN D STATUS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS

RADIOLOGICAL CERVICAL SPINE INVOLVEMENT IN JUVENILE IDIOPATHIC ARTHRITIS IN ADULTHOOD

HEPATITIS B IMMUNITY IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AT DISEASE ONSET.


THE QUALITY OF LIFE OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH ETANERCEPT IN COMBINATION WITH METHOTREXATE

EFFICACY AND SAFETY OF THERAPY BY ETANERCEPT IN COMBINATION WITH METHOTREXATE FOR PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS

ASSOCIATION BETWEEN VITAMIN D DEFICIENCY AND DISEASE ACTIVITY IN JUVENILE IDIOPATHIC ARTHRITIS


HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS

BIOLOGICAL THERAPY IN PATIENTS WITH CHRONIC JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS: RESULTS OF FOLLOW-UP IN A MULTIDISCIPLINARY UNIT

CERTOLIZUMAB IN JUVENILE IDIOPATHIC ARTHRITIS (JIA): EXPERIENCE OF 12 PATIENTS TREATED

GOLIMUMAB IN 25 YOUNG ADULTS AFFECTED BY JUVENILE IDIOPATHIC ARTHRITIS (JIA) NON RESPONDERS TO OTHER BIOLOGICAL AGENTS: PRELIMINARY DATA.

PREDICTABLE AND UNEXPECTED EFFECTS OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
[I am glad to see that the newer meds are being studied in JIA kids. I know how scary it is for a parent to allow their child to be on a study drug, but it's an important thing for not only their child but others. If I were in that position, I'd likely not hesitate to try a study drug. But that may be due to the fact I was a study drug kid. For ibuprofen and naproxen.]

TUMOUR NECROSIS FACTOR-BLOCKING AGENTS IN PERSISTENT OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE DUTCH ARTHRITIS AND BIOLOGICALS IN CHILDREN REGISTER

POLYMORPHISMS OF D6S273 MICROSATELLITE: POTENTIAL BASIS FOR DIFFERENTIATING HLA-B27/B7 POSITIVE PATIENTS WITH POLYARTICULAR COURSE OF JIA FROM JUVENILE SPONDYLOARTHRITIS PATIENTS?

SAFETY AND EFFICACY OF A 12-MO CANAKINUMAB ADMINISTRATION IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM THE GREEK NATIONAL REGISTRY.

COMPARISON OF THE PREVALENCE OF PROXY- OR SELF-REPORTED SIDE EFFECTS OF METHOTREXATE ADMINISTERED ORALLY, SUBCUTANEOUSLY OR INTRAMUSCULARLY IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS

SUBCLINICAL TEMPORO-MANDIBULAR JOINT (TMJ) INVOLVEMENT IN JUVENILE IDIOPATHIC ARTHRITIS (JIA) DETECT BY SCREENING IMAGING

EFFECTS OF INFLIXIMAB TREATMENT ON GROWTH IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA).

SUSTAINED MAINTENANCE OF ADAPTED ACR PEDIATRIC RESPONSE WITH CANAKINUMAB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
[Canakiumab is another new med for me.So went to Wiki again.

Canakinumab (INN, trade name Ilaris, previously ACZ885)[1] is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.[2] ...Canakinumab was being developed by Novartis for the treatment of rheumatoid arthritis but this trial has been discontinued.[5] Canakinumab is also in phase I clinical trials as a possible treatment for chronic obstructive pulmonary disease.[6]

MACROPHAGE ACTIVATION SYNDROME AS THE PRESENTING MANIFESTATION OF SYSTEMIC JUVENILE ARTHRITIS: UNICENTER STUDY OF CLINICAL FEATURES AND OUTCOME IN 12 PATIENTS

EPIDEMIOLOGY OF JUVENILE IDIOPATHIC ARTRITIS-ASSOCIATED UVEITIS IN SPAIN: RESULTS FROM A NATIONAL REGISTRY

TOTAL HIP REPLACEMENT IN YOUNG PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS

ASPECTS OF TEMPOROMANDIBULAR JOINT ARTHRITIS-RELATED OROFACIAL SYMPTOMS IN JUVENILE IDIOPATHIC ARTHRITIS

JUVENILE IDIOPATHIC ARTHRITIS: ATTITUDE OF PARENTS TO THE CHILD'S DISEASE

JUVENILE IDIOPATHIC ARTHRITIS: INTERACTION OF ATTITUDE OF PARENTS AND CHILDREN TO THE DISEASE

EFFECT OF PSYCHOLOGICAL PECULIARITIES OF PERSONALITY OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON SELF-APPRAISAL OF QUALITY OF LIFE

ASSESSMENT OF QUALITY OF LIFE OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITH AID OF QUESTIONNAIRE CHQ

DEVELOPMENT OF CUT-OFF VALUES FOR HIGH DISEASE ACTIVITY IN JUVENILE IDIOPATHIC ARTHRITIS BASED ON THE JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE (JADAS)

PRELIMINARY ACTIVITY AND SEVERITY CRITERIA FOR JUVENILE IDIOPATHIC ARTHRITIS-RELATED UVEITIS

SAFETY AND EFFICACY OF ADALIMUMAB IN CHILDREN WITH ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AGED 2 TO <4 YEARS OR ≥4 YEARS WEIGHING <15 KG

EFFICACY AND SAFETY OF RITUXIMAB RETREATMENT IN REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

DOES EXCLUSION OF THE ESR FROM JADAS AFFECT VALIDITY IN THE CLINICAL SETTING IN ASSESSMENT OF NEW-ONSET JUVENILE INFLAMMATORY ARTHRITIS?

TRANSITION TO ADULTHOOD, PROFESSIONAL AND SOCIAL OUTCOME OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) PATIENTS: A FRENCH MULTICENTRIC STUDY BASED ON 353 PATIENTS.

RESULTS OF A MULTINATIONAL SURVEY REGARDING THE DEFINITION OF REMISSION IN JUVENILE IDIOPATHIC ARTHRITIS RELATED UVEITIS.

QUALITY OF LIFE OF JUVENILE IDIOPATHIC ARTHRITIS COHORT AT ADULTHOOD IN A TRANSITION PROGRAM

CLINICAL REMISSION IN 291 JUVENILE IDIOPATHIC ARTHRITIS PATIENTS TREATED WITH BIOLOGICAL AGENTS

OPG/RANK/RANKL IN PATHOGENESIS OF OSTEOPOROSIS OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) SUBTYPES

RADIOLOGICAL PERIPHERAL INVOLVEMENT AT HANDS, FEET AND HIPS IN YOUNG ADULTS WITH POLYARTICULAR IDIOPATHIC JUVENILE ARTHRITIS.

6DRUG SURVIVAL AND REASONS FOR DISCONTINUATION OF THE FIRST COURSE OF BIOLOGICAL THERAPY IN 301 JUVENILE IDIOPATHIC ARTHRITIS PATIENTS.

ACHIEVEMENT OF CLINICAL REMISSION IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AFTER A LONG-TERM (2 - 5 YEARS) ETANERCEPT EXPOSURE: A NATIONAL REFERRAL CENTER'S EXPERIENCE. (PRELIMINARY REPORT).

DOES INTENSE SYNOVIAL ENHANCEMENT IN TEMPOROMANDIBULAR JOINTS OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS CORRELATE WITH DISEASE ACTIVITY?

WHAT HAPPENS WHEN ETANERCEPT IS DISCONTINUED IN "REMISSION" IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS?

THE EFFICACY AND SAFETY OF IBANDRONIC ACID FOR INTRAVENOUS ADMINISTRATION FOR TREATMENT OF SEVERE SYSTEMIC OSTEOPOROSIS IN PATIENTS WITH JUVENILE ARTHRITIS

SAFETY AND EFFICACY OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC ONSET OF JUVENILE IDIOPATHIC ARTHRITIS

HIGH PREVALENCE OF HAND AND WRIST IMPAIRMENTS IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)

GLYCOSYLATION OF VITAMIN D BINDING PROTEIN REDUCED IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS AT RISK OF DISEASE EXTENSION

HOW TO TREAT JUVENILE IDIOPATHIC ARTHRITIS AND OTHER PAEDIATRIC RHEUMATIC DISEASES

THE YOUNG ADULT WITH JUVENILE IDIOPATHIC ARTHRITIS - KEY CLINICAL ISSUES

LONG-TERM SAFETY OF ADALIMUMAB IN PATIENTS FROM GLOBAL CLINICAL TRIALS IN RHEUMATOID ARTHRITIS, JUVENILE IDIOPATHIC ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, PSORIASIS, AND CROHN'S DISEASE

EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT FOR REFRACTORY JUVENILE IDIOPATHIC ARTHRITIS – ASSOCIATED UVEITIS.

TOCILIZUMAB-EFFECTS ON GROWTH IMPAIRMENT IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

PREDICTORS OF ACHIEVEMENT OF INACTIVE DISEASE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH ETANERCEPT

DMARD USE IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: A CROSS-SECTIONAL ANALYSIS OF THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) REGISTRY

DO SERUM BIOMARKERS OF BONE AND OF CARTILAGE DEGRADATION REFLECT STRUCTURAL DAMAGE IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)?

A WAITLIST CONTROLLED TRIAL OF THE EFFICACY OF A PSYCHOLOGICAL TREATMENT PROGRAM FOR CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND THEIR PARENTS

INCIDENCE OF SELECTED OPPORTUNISTIC INFECTIONS AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS

PREDICTORS OF POOR GROWTH IN CHILDREN WITH EARLY JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY (CAPS)

HIGHER DISEASE ACTIVITY AND EARLIER ARTHRITIS ONSET ARE ASSOCIATED WITH RISK OF CORONARY HEART DISEASE DEVELOPMENT IN PATIENTS WITH PSORIATIC ARTHRITIS

INCREASED RISK OF DIASTOLIC HEART FAILURE IN RA – WHAT SHOULD WE SCREENING FOR ?

INCREASED RATE OF DIASTOLIC HEART FAILURE IN RHEUMATOID ARTHRITIS CORRELATES WITH SYSTEMIC INFLAMMATION AND PERSISTENT DISEASE ACTIVITY, INDEPENDENT FROM TREATMENT STRATEGY

DEPRESSIVE SYMPTOMS AND HEART RATE VARIABILITY IN PATIENTS WITH FIBROMYALGIA

PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS

CARDIOVASCULAR DISEASE IS RELATED TO DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS

COMPARISON OF EUROPEAN SCORE AND TWO NATIONAL GUIDELINES CALIBRATED FOR CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH PSORIATIC ARTHRITIS

HIGH FREQUENCY OF CARDIOVASCULAR DISEASE IN PATIENTS WITH KNEE OSTEOARTHRITIS IN A PRIMARY CARE SETTING

THE RISK OF CARDIOVASCULAR EVENTS IS INCREASED IN PEOPLE WITH GLUCOCORTICOID-INDUCED LIPODYSTROPHY

RHEUMATIC DISEASES AND CARDIOVASCULAR RISK: IMPLICATIONS FOR CLINICAL PRACTICE


PICTURING THE PROBLEM: CARDIOVASCULAR DISEASE IMPACT IN INFLAMMATORY RHEUMATIC DISEASES


SCREENING AND ASSESSING CARDIOVASCULAR RISK IN INFLAMMATORY ARTHRITIS


WHY IS CARDIOVASCULAR TRAINING IMPORTANT IN PEOPLE WITH RHEUMATIC DISEASE?

IMPLEMENTATION OF EFFECTIVE CARDIOVASCULAR TRAINING PRINCIPLES IN DAILY PRACTICE

ASSOCIATION OF ACID PHOSPHATASE LOCUS 1*C ALLELE WITH THE RISK OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS

REDUCED ENDOTHELIUM-INDEPENDENT VASCULAR REACTIVITY IS INDICATIVE OF CAROTID ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITHOUT OVERT CARDIOVASCULAR DISEASE

USE OF CARDIOVASCULAR DRUGS IN PATIENTS WITH RA, OVERALL AND IN PATIENTS WITH A HISTORY OF ACUTE ISCHEMIC CARDIAC EVENTS

ASSESSING THE CARDIOVASCULAR RISK BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS: ROLE OF ANNUAL REVIEW CLINIC
CARDIOVASCULAR SAFETY FINDINGS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB (CP-690,550), A NOVEL, ORAL JAK INHIBITOR

HIGH RATE OF CARDIOVASCULAR EVENTS IN LUPUS PATIENTS AT 5 YEAR FOLLOW UP AND ASSOCIATION OF CLASSICAL AND LUPUS RELATED RISK FACTORS

FUNCTIONAL VARIANT IN THE IFNG GENE PREDISPOSES TO CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS

WHO SHOULD CONTROL THE CLASSICAL CARDIOVASCULAR RISK FACTORS IN THE RHEUMATOID ARTHRITIS? STUDY ON THE CONSISTENCY BETWEEN PRIMARY CARE AND RHEUMATOLOGY

PREDICTORS OF OVERALL/CARDIOVASCULAR MORTALITY IN PATIENTS WITH EARLY INFLAMMATORY POLYARTHRITIS; THE LIPID-PARADOX?

USE OF ANTI-TNF THERAPY IS ASSOCIATED WITH REDUCED CARDIOVASCULAR EVENT RISK IN RHEUMATOID ARTHRITIS

EXERCISE ON STATIONARY BIKES IN PATIENTS WITH RHEUMATOID ARTHRITIS: POSITIVE EFFECTS ON CARDIOVASCULAR RISK FACTORS.

IMPACT OF ERGOMETRIC TEST IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS, WITHOUT CARDIOVASCULAR SYMPTOMS, BEFORE STARTING A SUPERVISED PHYSICAL ACTIVITY PROGRAM

DOES CARDIOVASCULAR DISEASE INCREASE THE RISK OF SICK LEAVE AND WORK DISABILITY AMONG PATIENTS WITH RHEUMATIC DISEASE?

EVALUATION OF EARLY MARKERS OF CARDIOVASCULAR RISK IN SUBJECTS AFFECTED BY SYSTEMIC RHEUMATIC DISEASES

THE EFFECT OF ADALIMUMAB ON RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMIZED TRIALS

TNF-BLOCKING THERAPY REDUCES CARDIOVASCULAR DISEASE AND RISK FACTORS IN RHEUMATOID ARTHRITIS

RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR (CV) EVENTS (MACE) IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH TOCILIZUMAB (TCZ)

EVALUATION OF THE USE OF THE CARDIOVASCULAR RISK SCORE TABLES IN PATIENTS WITH RHEUMATOID ARTHRITIS

RHEUMATOID ARTHRITIS PATIENTS WITH HIGHER DISEASE SEVERITY AND SUBCLINICAL CAROTID PLAQUE EXPERIENCE MORE CARDIOVASCULAR EVENTS DESPITE A FAVORABLE CONVENTIONAL CADIOVASCULAR RISK PROFILE

IMPROVEMENT IN SOME, BUT NOT ALL, SURROGATE MEASURES OF CARDIOVASCULAR DISEASE FOLLOWING INTENSIVE TREATMENT OF EARLY RHEUMATOID ARTHRITIS.

NON-STEROIDAL ANTI-INFLAMMATORY DRUG USE AND THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS - IS THERE A RISK ?

PREDICTING CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS: THE EFFECT OF LONG-TERM STORAGE ON MEASURED CHOLESTEROL LEVELS IN FROZEN SERUM SAMPLES.

SUSTAINED DEVELOPMENT OF CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS DESPITE CARDIOPROTECTIVE TREATMENT: THE 7-YEAR PROSPECTIVE CARRE-STUDY

IS CARDIOVASCULAR MORBIDITY AND MORTALITY INCREASED IN WORKING INDIVIDUALS WITH INFLAMMATORY RHEUMATIC DISEASES?

SUBSTANTIAL SUBCLINICAL CARDIOVASCULAR DYSFUNCTION IN INFLAMMATORY ARTHRITIS

DISH PREVALENCE IN PATIENTS AFFECTED BY SEVERE CARDIOVASCULAR DISEASES

ASSOCIATION BETWEEN CARDIOVASCULAR EVENTS AND CLASSIC CARDIOVASCULAR RISK FACTORS AND DISEASE CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS

THE CAROTID ARTERY ATHEROSCLEROSIS BURDEN AND ITS ASSOCIATED CARDIOVASCULAR RISK FACTORS IN AFRICAN BLACK AND CAUCASIAN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS

CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS: ARE WE AWARE?

CARDIOVASCULAR RISK FACTORS AND THEIR ASSOCIATION WITH BONE METABOLISM AND DISEASE ACTIVITY IN PATIENTS WITH EARLY ARTHRITIS

CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS PATIENTS USING THE SCORE CHART


NUMBER OF CARDIOVASCULAR RISK FACTORS MAY BE ASSOCIATED WITH HIGHER DISEASE ACTIVITY SEVERITY. EXPLORATORY ANALYSIS OF BASELINE DATA FROM THE CANADIAN MTX AND ETANERCEPT OUTCOME STUDY: A RANDOMIZED TRIAL OF ETANERCEPT AND MTX VS ETANERCEPT ALONE IN RA

INFLUENCE OF MHCIITA RS3087456 AND RS4774 POLYMORPHISMS IN THE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASE OF PATIENTS WITH RHEUMATOID ARTHRITIS

VALIDATION OF ICD-10 CODES FOR STROKE IN PATIENTS WITH RHEUMATOID ARTHRITIS

RHEUMATOLOGISTS PLAY A KEY ROLE IN SHARED DECISION-MAKING WITH PATIENTS IN THE CHOICE TO INITIATE BIOLOGIC THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS

REMISSION RATES INCREASE SUBSTANTIALLY BY ADDING ADALIMUMAB TO METHOTREXATE AND INTRA-ARTICULAR GLUCOCORTICOID IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS - 1-YEAR RESULTS OF INVESTIGATOR-INITIATED, DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL (OPERA)

INDUCTION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE VERSUS METHOTREXATE MONOTHERAPY IN RECENT ONSET RHEUMATOID ARTHRITIS (RA) – AN INVESTIGATOR INITIATED RANDOMIZED CONTROLLED TRIAL

TARGETED TREATMENT WITH COMBINATION DMARDS PRODUCES EXCELLENT CLINICAL AND RADIOGRAPHIC LONG-TERM OUTCOMES IN EARLY RHEUMATOID ARTHRITIS REGARDLESS OF INITIAL INFLIXIMAB. THE 5-YEAR FOLLOW-UP RESULTS OF THE NEO-RACO TRIAL.

TREATMENT PATTERNS IN PSORIATIC ARTHRITIS (PSA) PATIENTS NEWLY INITIATED ON ORAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)

POTENTIALLY HARMFUL PRESCRIPTION OF NSAIDS IN A PRIMARY CARE POPULATION WITH MUSCULOSKELETAL COMPLAINTS

DEVELOPMENT OF A HEALTH INDEX TO ASSESS THE BURDEN OF DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS – FIRST STEPS OF A GLOBAL INITIATIVE BASED ON THE ICF GUIDED BY ASAS

THE NEGATIVE EFFECTS OF GLUCOCORTICOIDS ON BONE ARE PRIMARILY MEDIATED BY GENES INVOLVED IN OSTEOBLAST DIFFERENTIATION AND BONE REMODELLING

SINOVIAL FLUID CYTOKINES RATHER THAN SYNOVIAL INFLAMMATORY CELL INFILTRATES MAY DIFFERENTIATE RHEUMATOID ARTHRITIS ACCORDING TO THE ACPA STATUS

THE USEFULNESS OF A MUSCULOSKELETAL ULTRASOUND (MUS) SCORING SYSTEM FOR 22 HAND JOINTS EXAMINATION FOR THE DETECTION OF EARLY UNDIFFERENTIATED INFLAMMATORY ARTHRITIS AND TREATMENT DECISIONS MAKING IN ESTABLISHED INFLAMMATORY ARTHRITIS.

PREDICTIVE VALUE OF EXERCISE STRESS TEST (24H TEST&RE-TEST) AND COGHEALTH© IN DIFFERENTIAL DIAGNOSIS OF CHRONIC FATIGUE SYNDROME VS. FIBROMYALGIA

RESPONSE TO ABATACEPT AND TOCILIZUMAB IN PATIENTS WHO HAD FAILED RITUXIMAB– INITIAL SINGLE CENTRE EXPERIENCE

REMISSION AFTER ONE YEAR FOLLOW UP OF THE IMPROVED-STUDY, A RANDOMIZED CLINICAL TRIAL AIMING AT REMISSION IN PATIENTS WITH EARLY RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS.

RISK FACTORS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS.

DIFFERENTIAL IMPACT OF TRADITIONAL CARDIAC RISK FACTORS ON CORONARY PLAQUE PREVALENCE IN CORONARY ARTERY DISEASE (CAD)-NAÏVE SUBJECTS WITH RHEUMATOID ARTHRITIS COMPARED TO CONTROLS

FACTORS ASSOCIATED WITH SERUM IL-6 LEVELS IN PATIENTS WITH EARLY ARTHRITIS.

IL-6 BLOCKADE ENHANCES THE THERAPEUTIC EFFECT OF STEROIDS

LOW DOSE METHOTREXATE PROTECTS RHEUMATOID ARTHRITIS BONE MASS AGAINST CORTICOSTEROID INDUCED BONE LOSS
INFLUENCE OF DOSE TITRATION OF CONCOMITANT STEROID AND METHOTREXATE DURING BIOLOGIC THERAPY ON REMISSION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE NEW ACR/EULAR REMISSION CRITERIA IN DAILY PRACTICE BASED ON THE IORRA COHORT

MORE CORTICOSTEROIDS AND LESS BIOTHERAPY IN ELDERLY RA PATIENTS : RESULTS ON A SURVEY ON 454 RA.

STEROID-SPARING EFFECT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS

THE USE OF GLUCOCORTICOSTEROIDS DOES NOT DISMISS THE LUMBAR BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, PROSPECTIVE STUDY.

EFFICACY AND SAFETY OF STEROID INJECTIONS FOR SHOULDER PAIN

EVALUATION OF A PATIENT REPORTED OUTCOME (PRO) BASED TOOL FOR THE ASSESSMENT OF SINGLE JOINT INTRAARTICULAR GLUCOCORTICOSTEROID INJECTION.

EARLY GLUCOCORTICOSTEROID RESPONSE PREDICTS THE EFFECT OF DMARDS AFTER 3 MONTHS OF THERAPY

STEROIDS AND LEFLUNOMIDE, NOT BIOLOGICS, ARE THE MAJOR RISK FACTORS FOR INFECTION FOLLOWING TOTAL JOINT ARTHROPLASTY [this is not a good thing for me if I need joint arthroplasty since this is part of my "cocktail" of drugs.]

EFFICACY OF HYDROXYCHLOROQUINE THERAPY ON WHOLE SALIVARY COMPONENTS IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME

No comments:

Post a Comment